JPRN-UMIN000029147
Completed
未知
Multicenter Prospective Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer - Multicenter Prospective Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
Yamaguchi Pancreatic / Biliary Disease Study Group0 sites50 target enrollmentSeptember 30, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yamaguchi Pancreatic / Biliary Disease Study Group
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients judged unsuitable as research subjects
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.JPRN-UMIN000046338Sapporo Medical University24
Recruiting
Not Applicable
Prospective study of neoadjuvant chemotherapy with FEC100x4 for BRCAness cases in triple negative breast cancerBreast cancerJPRN-UMIN000029433Tokyo medical university70
Completed
Not Applicable
A Prospective Study of Neoadjuvant Chemotherapy with Nivolumab/Gemcitabine/Cisplatin in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderKCT0003804Samsung Medical Center48
Recruiting
Not Applicable
A prospective cohort study of neoadjuvant chemotherapy using carboplatin and dose dense paclitaxel for locally advanced cervical cancerCervical cancerJPRN-UMIN000031670Hyogo Cancer Center100
Recruiting
Not Applicable
Prospective cohort study of neoadjuvant chemotherapy using tri-weekly carboplatin and weekly paclitaxel for patients with locally advanced cervical cancercervical cancerJPRN-UMIN000024136Hyogo Cancer CEnter100